{
    "relation": [
        [
            "",
            "Number of Participants [units: participants]",
            "Age [units: Months] Mean (Standard Deviation)",
            "Gender [units: Participants]",
            "Female",
            "Male"
        ],
        [
            "Losartan Potassium 0.1 to 1.4 mg/kg",
            "33",
            "40.2 (24.4)",
            "",
            "13",
            "20"
        ],
        [
            "Losartan Potassium 0.3 to 1.4 mg/kg",
            "34",
            "45.0 (21.5)",
            "",
            "16",
            "18"
        ],
        [
            "Losartan Potassium 0.7 to 1.4 mg/kg",
            "34",
            "40.6 (21.2)",
            "",
            "14",
            "20"
        ],
        [
            "Total",
            "101",
            "42.0 (22.3)",
            "",
            "43",
            "58"
        ]
    ],
    "pageTitle": "Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337) - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00756938?term=A+Phase+III%2C+Randomized%2C+Open-Label%2C+Parallel-Group%2C+Dose-",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 9,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042987135.9/warc/CC-MAIN-20150728002307-00312-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 859612719,
    "recordOffset": 859597420,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Period 1: \u00a0 12-week Base Study Participant Flow for 2 periods Participants who elected to enter extension; dose level of Losartan was that which was being administered at end of base study Losartan Potassium-Extension Open-label losartan at starting dose of 0.7 mg/kg/day with uptitration at Week 3, 6, or 9 to the next highest dose level if blood pressure goal not achieved Losartan Potassium 0.7 to 1.4 mg/kg Open-label losartan at starting dose of 0.3 mg/kg/day with uptitration at Weeks 3, 6 or 9 to the next highest dose level if blood pressure goal not achieved Losartan Potassium 0.3 to 1.4 mg/kg Open-label losartan at starting dose of 0.1 mg/kg/day with uptitration at Weeks 3, 6, or 9 to the next highest dose level if blood pressure goal not achieved Losartan Potassium 0.1 to 1.4 mg/kg Description \u00a0 Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment",
    "textAfterTable": "Lost to Follow-up \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 0 \u00a0 Period 2: \u00a0 Optional Extension \u00a0 \u00a0 Losartan Potassium 0.1 to 1.4 mg/kg \u00a0 \u00a0 Losartan Potassium 0.3 to 1.4 mg/kg \u00a0 \u00a0 Losartan Potassium 0.7 to 1.4 mg/kg \u00a0 \u00a0 Losartan Potassium-Extension \u00a0 STARTED \u00a0 \u00a0 0 \u00a0 \u00a0 0 \u00a0 \u00a0 0 \u00a0 \u00a0 90 [1] COMPLETED \u00a0 \u00a0 0 \u00a0 \u00a0 0 \u00a0 \u00a0 0 \u00a0 \u00a0 53 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}